| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |